SUVENNSESuven Life Sciences Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 9 Jul · 10:58 IST

Suven Life Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Suven Life Sciences has submitted a routine compliance certificate to the stock exchanges for the quarter ended June 30, 2025. The certificate, issued by the company's Registrar and Transfer Agent KFin Technologies Limited, confirms that details of securities dematerialized and rematerialized during the quarter have been furnished to both NSDL and CDSL as well as the stock exchanges (BSE and NSE) where the company's shares are listed. This is filed under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. There are no financial numbers, business updates, or corporate actions mentioned in the filing.

Likely market impact

This is a standard procedural compliance filing with no material impact on the business, share price, or shareholders. It simply confirms the routine reporting of share dematerialization activity for the quarter.